Changes in hepatitis B virus serology in bone marrow transplanted children

Pediatric Transplantation

Volumn 6, Issue 5, 2002, Pages 406-410

  Küpeli, Serhan ^a   Özen, Hasan ^a   Uçkan, Duygu ^a   Çetin, Mualla ^a   Tuncer, Murat ^a   Aypar, Ebru ^a   Tezcan, Ilhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adoptive immunity; Bone marrow transplantation; Hepatitis B

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; METHOTREXATE;

ADOPTIVE TRANSFER; ARTICLE; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; EVALUATION; FEMALE; GRAFT REJECTION; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DONOR; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; SEROCONVERSION; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS REPLICATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; MALE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 0036802557     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.02037.x     Document Type: Article

References (22)

1. Robertson KA. Bone marrow transplantation. In: Behrman, RE, Kliegman, RM, Jenson, HB, eds. Nelson Textbook of Pediatrics. Philadelphia: W.B. Saunders Company, 2000: 634-644.
2. Lawrence GL. Immune recovery after bone marrow transplantation. Hematol/Oncol Clin N Am 1990: 4: 659-675.
3. Chen PM, Fan S, Liu CJ, et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990: 49: 708-713.
4. Scullard GH, Coleman IS, Merigan CT, et al. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1991: 81: 987-991.
5. Dhedin N, Douvin C, Kuentz M. Reverse seroconversion of hepatitis B after allogenic bone marrow transplantation. Transplantation 1998: 66: 616-619.
6. Iwai K, Tashima M, Itoh M. Fulminant hepatitis B following bone marrow transplantation in an HBsAg negative, HBsAb positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant 2000: 25: 105-108.
7. Chen P, Chiou T, Fan FS, et al. Fulminant hepatitis is significantly increased in hepatitis B carriers after allogenic bone marrow transplantation. Transplantation 1999: 67: 1425-1433.
8. Reed EC, Myerson D, Corey L, Meyers JD. Allogenic bone marrow transplantation in patients positive for hepatitis B surface antigen. Blood 1991: 77: 195-200.
9. Üstün C, Koç H, Karayalçýn S, et al. Hepatitis B virus infection in allogenic bone marrow transplantation. Bone Marrow Transplant 1997: 20: 289-296.
10. Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management. Blood 1999: 93: 1127-1136.
11. Lau GKK, Liang R, Lee CK, et al. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core and anti-hepatitis B surface antibody positive. J Infect Dis 1998: 178: 1585-1591.
12. Brugger SA, Oesterreicher C, Hofmann H, et al. Hepatitis B virus clearanee by transplantation of bone marrow from hepatitis B immunized donor. Lancet 1997: 349: 996-997.
13. Doganci L, Arpaci F, Yalçin A. Bone marrow transplantation. Hope for the treatment of chronic hepatitis B. Am J Gastroenterol 2000: 95: 852-853.
14. Lau GKK, Liang R, Lee CK, Lim WL. Is vaccination of donor adequate for clearance of hepatitis B virus after bone marrow transplantation. Lancet 1997: 349: 1626-1627.
15. Locasciulli A, Testa M, Valsecchi MG, et al. The role of hepatitis B and C virus infections as risk factors for severe liver complications following allogenic BMT. A prospective study by the infectious disease Working Party of the European Blood and Marrow Transplantation Group. Transplantation 1999: 68: 1486-1491.
16. Locasciulli A, Alberti A, De Bock R, et al. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: A survey from the European Bone Marrow Transplantation Group - Infectious Diseases Working Party. Bone Marrow Transplant 1994: 14: 833-837.
17. Lau GK, Lok AS, Liang RH, et al. Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer. Hepatology 1997: 25: 1497-1501.
18. Bain VG. Hepatitis B in transplantation. Transpl Infect Dis 2000: 2: 153-165.
19. Endo T, Sakai T, Fujimoto K, et al. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 2001: 27: 433-436.
20. Iwai K, Tashima M, Itoh M, et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant 2000: 25: 105-108.
21. Avigan D, Pirofski LA, Lazarus HM. Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001: 7: 171-183.
22. Ilan Y, Nagler A, Zeira E, et al. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Bone Marrow Transplant 2000: 26: 633-638.